BlackRock’s Lifecore Biomedical LFCR Stock Holding History

BlackRock’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.98M	Sell	1,877,305 -29,779	-2%	-$206K	﹤0.01%	3699
2025 Q4	$15.6M	Buy	1,907,084 +66,442	+4%	+$492K	﹤0.01%	3223
2025 Q3	$13.5M	Sell	1,840,642 -34,184	-2%	-$259K	﹤0.01%	3291
2025 Q2	$15.2M	Buy	1,874,826 +109,907	+6%	+$741K	﹤0.01%	3172
2025 Q1	$12.4M	Buy	1,764,919 +148,438	+9%	+$922K	﹤0.01%	3203
2024 Q4	$12M	Buy	1,616,481 +103,535	+7%	+$661K	﹤0.01%	3331
2024 Q3	$7.46M	Buy	1,512,946 +60,312	+4%	+$315K	﹤0.01%	3552
2024 Q2	$7.45M	Buy	1,452,634 +973,818	+203%	+$5.77M	﹤0.01%	3531
2024 Q1	$2.54M	Sell	478,816 -120,484	-20%	-$862K	﹤0.01%	3918
2023 Q4	$3.71M	Buy	599,300 +87,873	+17%	+$610K	﹤0.01%	3807
2023 Q3	$3.86M	Sell	511,427 -20,616	-4%	-$188K	﹤0.01%	3765
2023 Q2	$5.14M	Sell	532,043 -1,366,452	-72%	-$8.35M	﹤0.01%	3719
2023 Q1	$7.17M	Buy	1,898,495 +50,342	+3%	+$281K	﹤0.01%	3478
2022 Q4	$12M	Buy	1,848,153 +40,907	+2%	+$337K	﹤0.01%	3311
2022 Q3	$16.1M	Sell	1,807,246 -94,776	-5%	-$964K	﹤0.01%	3154
2022 Q2	$19M	Buy	1,902,022 +9,344	+0.5%	+$92.5K	﹤0.01%	3120
2022 Q1	$21.9M	Sell	1,892,678 -53,780	-3%	-$599K	﹤0.01%	3113
2021 Q4	$21.6M	Sell	1,946,458 -165,724	-8%	-$1.61M	﹤0.01%	3228
2021 Q3	$19.5M	Sell	2,112,182 -93,227	-4%	-$1.01M	﹤0.01%	3293
2021 Q2	$24.8M	Buy	2,205,409 +22,251	+1%	+$256K	﹤0.01%	3166
2021 Q1	$23.1M	Buy	2,183,158 +92,128	+4%	+$1.04M	﹤0.01%	3104
2020 Q4	$22.7M	Buy	2,091,030 +151,075	+8%	+$1.56M	﹤0.01%	2931
2020 Q3	$18.9M	Sell	1,939,955 -50,193	-3%	-$478K	﹤0.01%	2882
2020 Q2	$15.8M	Sell	1,990,148 -33,432	-2%	-$345K	﹤0.01%	2920
2020 Q1	$17.6M	Buy	2,023,580 +11,869	+0.6%	+$124K	﹤0.01%	2678
2019 Q4	$22.8M	Buy	2,011,711 +60,849	+3%	+$648K	﹤0.01%	2808
2019 Q3	$21.2M	Buy	1,950,862 +66,543	+4%	+$724K	﹤0.01%	2781
2019 Q2	$17.7M	Sell	1,884,319 -10,305	-0.5%	-$104K	﹤0.01%	2915
2019 Q1	$23.3M	Sell	1,894,624 -153,931	-8%	-$1.88M	﹤0.01%	2668
2018 Q4	$24.3M	Buy	2,048,555 +46,011	+2%	+$632K	﹤0.01%	2616
2018 Q3	$28.8M	Buy	2,002,544 +52,199	+3%	+$722K	﹤0.01%	2679
2018 Q2	$29.1M	Buy	1,950,345 +92,444	+5%	+$1.28M	﹤0.01%	2653
2018 Q1	$24.2M	Sell	1,857,901 -15,082	-0.8%	-$198K	﹤0.01%	2658
2017 Q4	$23.6M	Buy	1,872,983 +18,293	+1%	+$231K	﹤0.01%	2691
2017 Q3	$24M	Buy	1,854,690 +15,483	+0.8%	+$204K	﹤0.01%	2696
2017 Q2	$27.3M	Sell	1,839,207 -10,270	-0.6%	-$143K	﹤0.01%	2602
2017 Q1	$22.2M	Buy	1,849,477 +1,842,928	+28,141%	+$23.3M	﹤0.01%	2690
2016 Q4	$91K	Sell	6,549 -807	-11%	-$11.2K	﹤0.01%	2604
2016 Q3	$98K	Buy	7,356 +333	+5%	+$4.03K	﹤0.01%	2603
2016 Q2	$76K	Buy	7,023 +5,398	+332%	+$59.5K	﹤0.01%	2705
2016 Q1	$17K	Buy	1,625 +918	+130%	+$10.1K	﹤0.01%	2921
2015 Q4	$8K	Hold	707	–	–	﹤0.01%	2986
2015 Q3	$8K	Hold	707	–	–	﹤0.01%	2830
2015 Q2	$10K	Hold	707	–	–	﹤0.01%	2785
2015 Q1	$10K	Hold	707	–	–	﹤0.01%	2736
2014 Q4	$10K	Hold	707	–	–	﹤0.01%	2768
2014 Q3	$9K	Hold	707	–	–	﹤0.01%	2790
2014 Q2	$9K	Hold	707	–	–	﹤0.01%	2854
2014 Q1	$8K	Hold	707	–	–	﹤0.01%	2857
2013 Q4	$9K	Hold	707	–	–	﹤0.01%	2780
2013 Q3	$9K	Hold	707	–	–	﹤0.01%	2710
2013 Q2	$9K	Buy	+707	New	+$9.78K	﹤0.01%	2704

Other funds holding LFCR

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return